Your browser doesn't support javascript.
loading
Improving the care of children with GENetic Rare disease: Observational Cohort study (GenROC)-a study protocol.
Low, Karen Jaqueline; Watford, Amy; Blair, Peter; Nabney, Ian; Powell, John; Wynn, Sarah L; Foreman, Julia; Firth, Helen; Ingram, Jenny.
Afiliación
  • Low KJ; Centre for Academic Child Health, University of Bristol, Bristol, UK karen.low@bristol.ac.uk.
  • Watford A; Department of Clinical Genetics, University Hospitals Bristol and Weston NHS Trust, Bristol, UK.
  • Blair P; Department of Clinical Genetics, University Hospitals Bristol and Weston NHS Trust, Bristol, UK.
  • Nabney I; Centre for Academic Child Health, University of Bristol, Bristol, UK.
  • Powell J; School of Computer Science, Electrical and Electronic Engineering and Engineering Maths, University of Bristol, Bristol, UK.
  • Wynn SL; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Foreman J; Unique Rare Chromosome Disorder Support Group, Oxted, UK.
  • Firth H; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK.
  • Ingram J; Clinical Genetics, Cambridge University Hospitals, Cambridge, UK.
BMJ Open ; 14(5): e085237, 2024 May 16.
Article en En | MEDLINE | ID: mdl-38760043
ABSTRACT

INTRODUCTION:

Around 2000 children are born in the UK per year with a neurodevelopmental genetic syndrome with significantly increased morbidity and mortality. Often little is known about expected growth and phenotypes in these children. Parents have responded by setting up social media groups to generate data themselves. Given the significant clinical evidence gaps, this research will attempt to identify growth patterns, developmental profiles and phenotypes, providing data on long-term medical and educational outcomes. This will guide clinicians when to investigate, monitor or treat symptoms and when to search for additional or alternative diagnoses. METHODS AND

ANALYSIS:

This is an observational, multicentre cohort study recruiting between March 2023 and February 2026. Children aged 6 months up to 16 years with a pathogenic or likely pathogenic variant in a specified gene will be eligible. Children will be identified through the National Health Service and via self-recruitment. Parents or carers will complete a questionnaire at baseline and again 1 year after recruitment. The named clinician (in most cases a clinical geneticist) will complete a clinical proforma which will provide data from their most recent clinical assessment. Qualitative interviews will be undertaken with a subset of parents partway through the study. Growth and developmental milestone curves will be generated through the DECIPHER website (https//deciphergenomics.org) where 5 or more children have the same genetic syndrome (at least 10 groups expected). ETHICS AND DISSEMINATION The results will be presented at national and international conferences concerning the care of children with genetic syndromes. Results will also be submitted for peer review and publication.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Raras País/Región como asunto: Europa Idioma: En Revista: BMJ Open Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Raras País/Región como asunto: Europa Idioma: En Revista: BMJ Open Año: 2024 Tipo del documento: Article